Literature DB >> 12038683

Antiserum raised against the Epstein-Barr virus BARF0 protein reacts to HLA-DR beta chain.

W Schroder1, N Kienzle, G Bushell, T Sculley.   

Abstract

The role that Epstein-Barr virus plays in nasopharyngeal carcinoma and Burkitt's lymphoma has been under intense study for many years. With only a limited set of viral genes being expressed in these tumours it has been difficult to understand how the virus could cause/aid in the generation of the tumours. In 1997 a paper was published by Fries et al. [Fries et al. (1997) Identification of a novel protein encoded by the BamH1 A region of the Epstein-Barr virus. J Virol 71: 2765-2771.] in which a rabbit serum was generated and used to identify protein products (RK-BARF0) encoded from the BamH1 A region of EBV. In this paper we have isolated these proteins from two-dimensional gels and identified them, using mass spectrometry, as components of HLA DR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12038683     DOI: 10.1007/s007050200021

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.

Authors:  Jiun-Han Lin; Ching-Hwa Tsai; Jan-Show Chu; Jeou-Yuan Chen; Kenzo Takada; Jin-Yuh Shew
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 2.  The role of miRNAs and EBV BARTs in NPC.

Authors:  Aron R Marquitz; Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2011-12-10       Impact factor: 15.707

3.  Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern.

Authors:  Natalie J Thornburg; Shuichi Kusano; Nancy Raab-Traub
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.